HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel autoantibodies against the activated coagulation factor IX (FIXa) in the antiphospholipid syndrome that interpose the FIXa regulation by antithrombin.

Abstract
We previously reported that some human antiphospholipid Abs (aPL) in patients with the antiphospholipid syndrome (APS) bind to the homologous enzymatic domains of thrombin and the activated coagulation factor X (FXa). Moreover, some of the reactive Abs are prothrombotic and interfere with inactivation of thrombin and FXa by antithrombin (AT). Considering the enzymatic domain of activated coagulation factor IX (FIXa) is homologous to those of thrombin and FXa, we hypothesized that some aPLs in APS bind to FIXa and hinder AT inactivation of FIXa. To test this hypothesis, we searched for IgG anti-FIXa Abs in APS patients. Once the concerned Abs were found, we studied the effects of the Ab on FIXa inactivation by AT. We found that 10 of 12 patient-derived monoclonal IgG aPLs bound to FIXa and that IgG anti-FIXa Abs in APS patients were significantly higher than those in normal controls (p < 0.0001). Using the mean + 3 SD of 30 normal controls as the cutoff, the IgG anti-FIXa Abs were present in 11 of 38 (28.9%) APS patients. Importantly, 4 of 10 FIXa-reactive monoclonal aPLs (including the B2 mAb generated against beta(2)-glycoprotein I significantly hindered AT inactivation of FIXa. More importantly, IgG from two positive plasma samples were found to interfere with AT inactivation of FIXa. In conclusion, IgG anti-FIXa Ab occurred in approximately 30% of APS patients and could interfere with AT inactivation of FIXa. Because FIXa is an upstream procoagulant factor, impaired AT regulation of FIXa might contribute more toward thrombosis than the dysregulation of the downstream FXa and thrombin.
AuthorsYao-Hsu Yang, Daniel Chien, Meifang Wu, John FitzGerald, Jennifer M Grossman, Bevra H Hahn, Kwan-Ki Hwang, Pojen P Chen
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 182 Issue 3 Pg. 1674-80 (Feb 01 2009) ISSN: 1550-6606 [Electronic] United States
PMID19155517 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antibodies, Antiphospholipid
  • Antibodies, Monoclonal
  • Antithrombins
  • Immunoglobulin G
  • Factor IXa
Topics
  • Adolescent
  • Adult
  • Aged
  • Antibodies, Antiphospholipid (blood, physiology)
  • Antibodies, Monoclonal (blood, metabolism, physiology)
  • Antiphospholipid Syndrome (blood, immunology)
  • Antithrombins (metabolism, physiology)
  • Binding Sites, Antibody
  • Factor IXa (antagonists & inhibitors, immunology, metabolism)
  • Female
  • Humans
  • Immunoglobulin G (blood, physiology)
  • Male
  • Middle Aged
  • Protein Binding (immunology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: